Literature DB >> 2964547

T cell activation through different membrane structures (T3/Ti, T11, T44) and frequency analysis of proliferating and interleukin-2 producer T lymphocyte precursors in aged individuals.

G W Canonica1, M Caria, D Venuti, G Cipro, G Ciprandi, M Bagnasco.   

Abstract

It is well known that the proliferative responsiveness of T cells of aged subjects is depressed in both autologous mixed lymphocyte reaction (AMLR) and in PHA-induced cultures. In the present study we analyzed T cell activation through different stimulatory pathways (such as T3/Ti antigen receptor, T11 complex and T44 molecule). Moreover, we studied Interleukin-2 (IL-2) release performing a limiting dilution analysis of the proliferative capability of peripheral blood T cells, employing a high efficiency cloning technique. Our results demonstrate normal proliferation of T3-induced T cells in aged subjects, whereas T11- and T44-induced T cell proliferations are depressed in aged subjects. In addition, studies at clonal level reveal a normal percentage of IL-2 producer T cell in aged individuals. In conclusion, our data suggest that the T cell in aged subjects are normal in number, but they have a decreased capacity of lymphokine production.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2964547     DOI: 10.1016/0047-6374(88)90060-7

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  3 in total

Review 1.  The effect of aging on host defences. Implications for therapy.

Authors:  A Scordamaglia; G Ciprandi; F Indiveri; G W Canonica
Journal:  Drugs Aging       Date:  1991 Jul-Aug       Impact factor: 3.923

2.  Characteristics and Distribution of Surgical Diseases in North Korean Research Papers Published between 2006 and 2017.

Authors:  Yo Han Lee; Namkee Oh; Hyerim Kim; Shin Ha
Journal:  J Korean Med Sci       Date:  2021-03-29       Impact factor: 2.153

3.  Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial.

Authors:  Andrzej Bożek; Krzysztof Kołodziejczyk; Renata Kozłowska; Giorgio Walter Canonica
Journal:  Clin Transl Allergy       Date:  2017-12-01       Impact factor: 5.871

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.